Home » Stocks » Spring Bank Pharmaceuticals » Financials » Income Statement

Spring Bank Pharmaceuticals, Inc. (SBPH)

Stock Price: $1.44 USD -0.02 (-1.37%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January-December.
Year201920182017201620152014
Revenue---0.350.950.74
Revenue Growth----62.79%28.18%-
Gross Profit---0.350.950.74
Selling, General & Admin9.758.728.185.745.002.41
Research & Development23.2719.7513.0814.027.546.13
Operating Expenses33.0228.4721.2519.7612.548.54
Operating Income-33.02-28.47-21.25-19.40-11.60-7.81
Interest Expense / Income0.54----1.91
Other Expense / Income-9.47-5.626.43-2.04-0.030.00
Pretax Income-24.10-22.85-27.68-17.37-11.56-9.71
Net Income-24.10-22.85-27.68-17.37-11.56-9.71
Shares Outstanding (Basic)16.4514.3711.157.265.683.12
Shares Outstanding (Diluted)16.4514.6211.157.265.683.12
Shares Change14.49%28.86%53.7%27.7%82.24%-
EPS (Basic)-1.46-1.59-2.48-2.39-2.03-3.11
EPS (Diluted)-1.46-1.88-2.48-2.39-2.03-3.11
Free Cash Flow Per Share-1.78-1.89-1.61-2.21-1.51-2.38
Gross Margin---100%100%100%
Operating Margin----5,512.5%-1,225.8%-1,057.7%
Profit Margin----4933.5%-1222.4%-1316%
FCF Margin----4,554.5%-909.1%-1,007.0%
EBITDA-23.20-22.57-27.52-17.25-11.48-7.76
EBITDA Margin----4900%-1213.1%-1051.9%
EBIT-23.56-22.85-27.68-17.37-11.56-7.81
EBIT Margin----4,933.5%-1,222.4%-1,057.6%